Small Intestinal Bacterial Overgrowth (SIBO)Small Intestinal Bacterial Overgrowth (SIBO)
Prevalência: Estimated 6-15% in healthy population; up to 80% in IBS patients
Evidence-Ranked Ingredients
| Ingrediente | Nota | Estudos | Direção | |
|---|---|---|---|---|
| Partially Hydrolyzed Guar Gum (PHGG) | C | 2 | Positive | Ver → |
| Berberine | C | 2 | Positive | Ver → |
About
A condition characterized by excessive bacterial colonization of the small intestine, typically defined as >10^5 CFU/mL on jejunal aspirate or positive lactulose/glucose hydrogen breath test. Causes malabsorption due to bacterial consumption of nutrients and bile acid deconjugation.
Common Symptoms
Risk Factors
- IBS
- Gastric acid suppression (PPIs)
- Structural abnormalities
- Diabetes
- Hypothyroidism
- Prior abdominal surgery
- Chronic opioid use
Frequently Asked Questions
What supplements are studied for Small Intestinal Bacterial Overgrowth (SIBO)?
How is the evidence for Small Intestinal Bacterial Overgrowth (SIBO) supplements graded?
How many studies on Small Intestinal Bacterial Overgrowth (SIBO) supplements have been reviewed?
What are common symptoms of Small Intestinal Bacterial Overgrowth (SIBO)?
Related Conditions
Condições que partilham ingredientes estudados
Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.